Drug
Opc 1085el
Opc 1085el: highest development phase Phase 3, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| OPC-1085EL NCT05583474 | Phase 3 | Open Angle Glaucoma or Ocular Hypertension |
Latest
No recent events.
Follow Opc 1085el on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.